NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GERN | Geron Corporation | Healthcare | Biotechnology | 6.88% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.23% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.82% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.78% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.77% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.71% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.65% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.56% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 5.56% |
| ANIP | ANI Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.19% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 4.15% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.94% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.9% |
| PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.84% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.71% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.66% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.65% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| INVA | Innoviva Inc | Healthcare | Biotechnology | 3.57% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.48% |
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.